6Polasek TM, Elliot DJ, Somogyi AA, et al. An evaluation of poten- tial mechanism-based inactivation of human drug metabolizing cy- tochromes P450 by monoamine oxidase inbibitors,including isonia- zid[J]. Br J Clin PharmacoI, 2006,61 ( 5 ) : 570-584.
7Martins MA,Reis AM,Sales MF,et al. Rifampicin-warfarin inter- action leading to macroscopic hematuria: a case report and review of the literature[J]. BMC Pharmacol Toxicol, 2013,14 : 27.
8Nishimura Y,Kurata N,Sakurai E,et al. Inhibitory effect of anti- tuberculosis drugs on human cytochrome P450-mediated activities [J]. J Pharmacol Sci,2004,96(3) :293-300.
9Yan F, Hu Y,Di B, et al. Effects of some antihypertensive drugs on the metabolism and pharmacokinetics of indapamide in rats[J]. J Pharm Pharm Sci,2012,15(2):208-220.
10Yang KH,Choi YH,Lee U,et al. Effects of cytochrome P450 in- ducers and inhibitors on the pharmacokinetics of intravenous furo-semide in rats: involvement of CYP2Cl1,2El ,3A1 and 3A2 in fu- rosemide metabolism[J]. J Pharm Pharmacol, 2009,61 (1) : 47-54.
9[1]Ondetti M A,Rubin B,Cushman DW. Design of specific inhibitors of angiotensin-converting enzyme: new class of orally active antihypertensive agents[J]. Science, 1977,196: 441-444.
10[2]Ondetti M A,Cushman DW. Enzymes of the renin angiotensin system and their inhibitors[J].Annu Rev Biochem, 1982,51:283-308.
